Evidence-based therapy for cutaneous sarcoidosis.
Most of treatments for cutaneous sarcoidosis are extensions of the drugs tested for pulmonary sarcoidosis. There are some exceptions. These include drugs given topically and those with high concentrations in the skin. This review will examine the conventional treatments of cutaneous sarcoidosis and focus on the best available evidence to make recommendations on treatment.
Baughman
Robert P
RP
Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45220, USA. bob.baughman@uc.edu <bob.baughman@uc.edu>
Lower
Elyse E
EE
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D012507:Sarcoidosis / Q000628:therapy*; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology*; D013792:Thalidomide / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D013792:Thalidomide; D008911:Minocycline; D008727:Methotrexate